Become A Research Partner

National Brain Tumor Society funds only the most promising research poised to deliver results. Our funded research has contributed to the establishment of many of what are now the top adult and pediatric brain tumor research labs across the country, as well as advances in understanding brain tumor makeup and what could drive more effective treatments.

By partnering with us and supporting our strategic initiatives, you can help advance the understanding of brain tumors, improve the availability of new treatments, and drive the discovery of a cure. Learn more about the initiatives that you can contribute to directly.

Defeat GBM

Glioblastoma multiforme (GBM) is a highly aggressive, complex, and devastating form of brain cancer, effecting hundreds of people each day. We believe it is our duty to accelerate progress against this disease so we launched the Defeat GBM Research Collaborative in 2013 with the intent to double the 5 year survival rate of GBM patients. This comes at a time when collaboration is becoming the norm and the abundance of genomic data is accelerating diagnostic, prognostic, and therapeutic progress.

Oligo Research Fund

Oligodendroglioma (oligo) is a relatively rare brain tumor representing about 6% of gliomas, with a diagnosis rate of about 1,150 patients a year in the U.S. alone. Critical research is required to deliver oligo patients new therapies that are more durable and extend their lives. In order to make effective, targeted therapies a reality it is essential to identify and understand the molecular drivers of the tumor’s genesis and maintenance, as well as resistance.

Pediatric Initiatives

Our new pediatric initiative, Project Impact, will leverage increases in knowledge gained from earlier funded research efforts, and develop a program that can address critical barriers to progress within the drug discovery and development pipeline through an integrated approach to advance research toward new treatments for pediatric brain tumor patients.

Community Research

The Community Research Fund allows contributors to pool donations to support research on a specific type of tumor. This program leverages a team of highly experienced, nationally-recognized scientific experts, working with National Brain Tumor Society staff, to determine the best investment strategy for each fund.


From the Blog

  • June 14, 2018

    Potential Brain Tumor Treatments Entering the Pivotal Phase of Evaluation – June 2018

    A large, randomized, controlled Phase III clinical trial is traditionally the last, pivotal step in the evaluation of a potential new medicine before it is approved for use by all patients with the indicated disease. A year ago, the NBTS

    Read More

  • June 13, 2018

    NBTS Brain Tumor Clinical Trials Report: Q2 2018

    New brain tumor clinical trials open around the country all the time, and it can be hard for patients and care-partners to keep track of new opportunities to potentially participate in leading-edge clinical research. This report, generated by the

    Read More

  • June 7, 2018

    Guest Blog: Marathon for a Mission – Gray Nation Endurance is Launched

    Nitesh V Patel, MD is a Neurosurgical resident in the Department of Neurosurgery at Rutgers University. On November 4th, 2018 he’ll be running in the TCS New York City Marathon to benefit the National Brain Tum

    Read More

More from the blog